Inhibition of MMP‐9‐mediated lung cancer migration and invasion via honokiol was evaluated in the present study, and the migration and invasion activity of H1299 lung cancer cells was suppressed under the noncytotoxic concentration of honokiol treatments (Figures 1 and 2). Here, MMP9 is linked to lung cancer.